ARCHIVES

In Brief: William Peters To Leave Duke To Head Michigan Cancer Foundation, Prentis Center

This article is from The Cancer Letter archive.

Vol. 21 No. 14 | April 7, 1995

Download PDF Visit The Full Archive

Related Articles

Crico-Pharyngeal Myotomoy To Be Assessed in Trial

October 4, 1985

Cooperative Group Chairman Objects “Personal” Comments, Other Deficiencies In Peer Review

January 16, 1981

NeoRx Suspends Accrual, Treatment In Phase III trial Using STR For Myeloma.

December 1, 2000

Schepartz New DCT Deputy Director; DeVita To Continue As Clinical Director

September 3, 1976

ASCO Draft Recommendations Define Meaningful Trial Outcomes

April 26, 2013

In Brief: No Intention Of Cutting Back On Cancer, Heart Research, Weinberger Spokesman Insists

June 7, 1974